• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Regeneron Pharmaceuticals

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Inc REGN 3 Star

Last Price$358.92Day Change (%)-1.05%
Open Price$364.83Day Change ($)-3.82
Day Range357.29–365.5952-Week Range257.69–369.31

As of Fri 09/19/2014 06:35 PM EST | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Regeneron Announces Submission of Application for EYLEA® (aflibercept) Injection in Japan for Macular Edema Following Branch Retinal Vein Occlusion

    Regeneron Announces Submission of Application for EYLEA® (aflibercept) Injection in Japan for Macular Edema Following Branch Retinal Vein Occlusion

  2. Regeneron and Sanofi Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014

    Regeneron and Sanofi Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014

  3. Despite bullish backdrop, technical tests are -6-

    Despite bullish backdrop, technical tests are -6-

  4. Despite bullish backdrop, technical tests are -2-

    Despite bullish backdrop, technical tests are -2-

  5. Despite bullish backdrop, technical tests are in play

    Despite bullish backdrop, technical tests are in play

  6. Despite bullish backdrop, technical tests are -7-

    Despite bullish backdrop, technical tests are -7-

  7. Despite bullish backdrop, technical tests are -3-

    Despite bullish backdrop, technical tests are -3-

  8. Despite bullish backdrop, technical tests are -5-

    Despite bullish backdrop, technical tests are -5-

  9. Despite bullish backdrop, technical tests are -4-

    Despite bullish backdrop, technical tests are -4-

  10. Sanofi and Regeneron Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014

    Sanofi and Regeneron Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.